Update on hepatobiliary and pulmonary flukes

Current Infectious Disease Reports

Volumn 1, Issue 5, 1999, Pages 427-433

  Hawn, Thomas R ^a   Jong, Elaine C ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cholangiocarcinoma; Fascioliasis; Nitazoxanide; Praziquantel; Worm Burden

Indexed keywords

EID: 0012565685     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-999-0054-y     Document Type: Article

References (49)

1. Hopkins DR: Homing in on helminths. Am J Trop Med Hyg 1992, 46:626–634.
2. Sithithaworn P, Tesana S, Pipitgool V et al.: Relationship between faecal egg count and worm burden of Opisthorchis viverrini in human autopsy cases. Parasitology 1991, 102:277–281.
3. Schwartz DA: Helminths in the induction of cancer: Opisthorchis viverrini, Clonorchis sinensis and cholangiocarcinoma. Trop Geogr Med 1980, 32:95–100.
4. Flavell DJ: Liver-fluke infection as an aetiological factor in bile-duct carcinoma of man. Trans R Soc Trop Med Hyg 1981, 75:814–824.
5. Petmir S: Cancer genes and cholangiocarcinoma. Southeast Asian J Trop Med Public Health 1997, 28:80–84. This paper describes differences in mutations in cholangiocarcinoma cancer genes in individuals from endemic and nonendemic areas for biliary fluke infections.
6. Hou PC: The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis. J Pathol Bacteriol 1956, 72:239–246.
7. Bhudhisawasdi V: Place of surgery in opisthorchiasis associated cholangiocarcinoma. Southeast Asian. J Trop Med Public Health 1997, 28:85–90.
8. Watanapa P: Cholangiocarcinoma in patients with opisthorchiasis. Br J Surg 1996, 83:1062–1064.
9. Curtale F, Nabil M, Wakeel A, et al.: Anaemia and intestinal parasitic infections among school age children in Behera Governorate, Egypt. J Trop Pediatr 1998, 44:323–328.
10. Han JK, Choi BI, Cho JM, et al.: Radiological findings of human fascioliasis. Abdom Imaging 1993, 18:261–264.
11. Hamajima F, Yamamoto M, Tsuru S, et al.: Immunosuppression by a neutral thiol protease from parasitic helminth larvae in mice. Parasite Immunol 1994, 16:261–273.
12. Rifkin M, Seow H, Jackson D, et al.: Defence against the immune barrage: helminth survival strategies. Immunol Cell Biol 1996, 74:564–574.
13. Carmona C, Dowd AJ, Smith A, et al.: Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Mol Biochem Parasitol 1993, 62:9–18.
14. Dalton JP, McGonigle S, Rolph TP, et al.: Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect Immun 1996, 64:5066–5074. This paper describes a protein that assists F. hepatica in evading the immune system and is also being tested as a possible subunit vaccine molecule.
15. Tendler M, Brito CA, Vilar MM, et al.: A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci U S A 1996, 93:269–273.
16. Akai PS, Pungpak S, Kitikoon V, et al.: Possible protective immunity in human opisthorchiasis. Parasite Immunol 1994, 16:279–288.
17. Bunnag D, Harinasuta T: Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel. Southeast Asian J Trop Med Public Health 1980, 11:528–531.
18. Chen M, Hua X, Wan Z, et al.: Praziquantel in 237 cases of Clonorchis sinensis. Chin Med J(Engl) 1983, 96:935–940.
19. Pungpak S, Bunnag D, Harinasuta T: Clinical and laboratory evaluation of praziquantel in opisthorchiasis. Southeast Asian J Med Public Health 1983, 14:363–366.
20. Rim H, Lyu K, Lee J, et al.: Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann Trop Med Parasitol 1981, 75:27–33.
21. Jong EC, Wasserheit JN, Johnson RJ, et al.: Praziquantel for the treatment of Clonorchis/Opisthorchis infections: report of a double-blind, placebo-controlled trial. J Infect Dis 1985, 152:637–640.
22. Yangco BG, De Lerma C, Lyman GH, et al.: Clinical study evaluating efficacy of praziquantel in clonorchiasis. Antimicrob Agents Chemother 1987, 31:135–138.
23. King CH, Mahmoud AAF: Drugs five years later: praziquantel. Ann Intern Med 1989, 110:290–296.
24. Jaroonvesama N, Charoenlarp K, Cross JH: Treatment of Opisthorchis viverrini with mebendazole. Southeast Asian J Trop Med Public Health 1981, 12:595–597.
25. Pungpak S, Bunnag D, Harinasuta T: Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections. Southeast Asian J Trop Med Public Health 1984, 15:46–50.
26. Farid Z, Mansour N, Kamal M, et al.: The treatment of acute Fasciola hepatica infection in children. Trop Geogr Med 1990, 42:95–96.
27. Farag HF, Salem A, El-Hifni SA, et al.: Bithionol (Bitin) treatment in established fascioliasis in Egyptians. J Trop Med Hyg 1988, 91:240–244.
28. Bassiouny HK, Soliman NK, El-Daly SM, et al.: Human fascioliasis in Egypt: effect of infection and efficacy of bithionol treatment. J Trop Med Hyg 1991, 94:333–337.
29. Bacq Y, Besnier J, Duong T, et al.: Successful treatment of acute fascioliasis with bithionol. Hepatology 1991, 14:1066–1069.
30. Arjona R, Riancho JA, Aguado JM, et al.: Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine 1995, 74:13–23.
31. Knobloch J, Delgado E, Alvarez AA, et al.: Human fascioliasis in Cajamarca/Peru: I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol 1985, 36:88–90.
32. Farid Z, Trabolsi B, Boctor F, et al.: Unsuccessful use of praziquantel to treat acute fascioliasis in children. J Infect Dis 1986, 154:920–921.
33. Farid Z, Kamal M, Mansour N: Praziquantel and Fasciola hepatica infection. Trans R Soc Trop Med Hyg 1989, 83:813.
34. Hardman EW, Jones RLH, Davies AH: Fascioliasis: a large outbreak. BMJ 1970, 3:502–505.
35. Chen MG, Mott KE: Progress in assessment of morbidity due to Fasciola hepatica infection: a review of the recent literature. Trop Dis Bull 1990, 87:R1-R38.
36. Apt W, Aguilera X, Vega F, et al.: Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 1995, 52:532–535. This paper describes an investigational drug for treating fascioliasis. Discovery of such drugs is important because of the limited availability of bithionol, which has been the primary medicine used for treatment.
37. Rossignol J, Abaza H, Friedman H: Successful treatment of human fascioliasis with nitazoxanide. Trans R Soc Trop Med Hyg 1998, 92:103–104. This paper describes an investigational drug for treating fascioliasis.
38. Eckhardt T, Heckers H: Treatment of human fascioliasis with niclofolan. Gastroenterology 1981, 81:795–798.
39. Nik-Akhtar B, Tabibi V: Metronidazole in fascioliasis: report of four cases. J Trop Med Hyg 1977, 80:179–180.
40. Johnson RJ, Jong EC, Dunning SB, et al.: Paragonimiasis: diagnosis and the use of praziquantel in treatment. Rev Infect Dis 1985, 7:200–206.
41. Calvopina M, Guderian R, Paredes W, et al.: Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. Trans R Soc Trop Med Hyg 1998, 92:566–569.
42. Ripert C, Couprie B, Moyou R, et al.: Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroon: a pilot study. Trans R Soc Trop Med Hyg 1992, 86:41.
43. Rim H: Epidemiology and control of clonorchiasis in Korea. Southeast Asian J Trop Med Public Health 1997, 28:47–50.
44. Song C, Duan Y, Shou G, et al.: Studies on the use of cobalt-60 gamma irradiation to control infectivity of Clonorchis sinensis metacercariae. Southeast Asian J Trop Med Hyg 1992, 23:71–76.
45. Saowakontha S, Pipitgool V, Pariyanonda S, et al.: Field trials in the control of Opisthorchis viverrini with an integrated programme in endemic areas of northeast Thailand. Parasitology 1993, 106:283–288. This paper describes a successful public health control program that used health education and medical treatment with praziquantel as the primary intervention measures.
46. Jongsuksuntigul P, Imsomboon T: The impact of a decade long opisthorchiasis control program in Northeastern Thailand. Southeast Asian J Trop Med Public Health 1997, 28:551–557.
47. Esteban J, Flores A, Aguirre C, et al.: Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano. Acta Trop 1997, 66:1–14. This paper on the epidemiology of fascioliasis describes a community with the highest known prevalence rate of this parasite.
48. Cho S, Kong Y, Kang S: Epidemiology of paragonimiasis in Korea. Southeast Asian J Trop Med Hyg 1997, 28:32–36.
49. Shim Y, Cho S, Han Y: Pulmonary paragonimiasis: a Korean perspective. Semin Respir Med 1991, 12:35–45.